This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Joseph A. Mozdzierz: Innovator in Anti-PD-1 Antibodies
Introduction
Joseph A. Mozdzierz is a notable inventor based in Mahopac, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic and diagnostic methods.
Latest Patents
Joseph A. Mozdzierz holds a patent for Anti-PD-1 antibodies. This invention relates to new anti-PD-1 (Programmed cell death 1) antibodies and antigen-binding fragments thereof. These antibodies are designed for therapeutic and diagnostic methods and compositions using them.
Career Highlights
Joseph A. Mozdzierz is associated with Boehringer Ingelheim International GmbH, where he continues to advance his research and innovations. His work focuses on enhancing the efficacy of treatments in immunotherapy.
Collaborations
Some of his notable coworkers include David A. Blair and Nicole K. Garaffa, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Joseph A. Mozdzierz is a prominent figure in the field of biotechnology, with a focus on anti-PD-1 antibodies that hold promise for therapeutic applications. His contributions are paving the way for advancements in cancer treatment and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile